Evidence map›Paper›PMID 23533312›Full record

ArticleMediators of inflammation2013

Radical scavenging activity-based and AP-1-targeted anti-inflammatory effects of lutein in macrophage-like and skin keratinocytic cells.

Jueun Oh, Ji Hye Kim, Jae Gwang Park, Young-Su Yi, Kye Won Park, Ho Sik Rho, Min-Seuk Lee, Jae Won Yoo, Seung-Hyun Kang, Yong Deog Hong and 2 more

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 65 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Phytochemicals Analysis,Journal of tropical medicine · 2023
    Article
  5. Carotenoids from Persimmon (Pharmaceutics · 2021
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Evaluation of the anti-gout effect ofMedicine and pharmacy reports · 2021
    Article
  12. Article
  13. Article
  14. Skimmin Improves Insulin ResistanceFrontiers in pharmacology · 2020
    Article
  15. Review
  16. Article
  17. Antioxidative and Antimelanogenesis Effect ofEvidence-based complementary and alternative medicine : eCAM · 2019
    Article
  18. Article
  19. Review
  20. Carotenoids: biochemistry, pharmacology and treatment.British journal of pharmacology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Jueun OhDepartment of Genetic Engineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea.
Ji Hye Kim
Jae Gwang Park
Young-Su Yi
Kye Won Park
Ho Sik Rho
Min-Seuk Lee
Jae Won Yoo
Seung-Hyun Kang
Yong Deog Hong
Song Seok Shin
Jae Youl Cho
Sungkyunkwan University · KRAmorepacific (South Korea) · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lutein is a naturally occurring carotenoid with antioxidative, antitumorigenic, antiangiogenic, photoprotective, hepatoprotective, and neuroprotective properties. Although the anti-inflammatory effects of lutein have previously been described, the mechanism of its anti-inflammatory action has not been fully elucidated. Therefore, in the present study, we aimed to investigate the regulatory activity of lutein in the inflammatory responses of skin-derived keratinocytes or macrophages and to elucidate the mechanism of its inhibitory action. Lutein significantly reduced several skin inflammatory responses, including increased expression of interleukin-(IL-) 6 from LPS-treated macrophages, upregulation of cyclooxygenase-(COX-) 2 from interferon- γ /tumor necrosis-factor-(TNF-) α -treated HaCaT cells, and the enhancement of matrix-metallopeptidase-(MMP-) 9 level in UV-irradiated keratinocytes. By evaluating the intracellular signaling pathway and the nuclear transcription factor levels, we determined that lutein inhibited the activation of redox-sensitive AP-1 pathway by suppressing the activation of p38 and c-Jun-N-terminal kinase (JNK). Evaluation of the radical and ROS scavenging activities further revealed that lutein was able to act as a strong anti-oxidant. Taken together, our findings strongly suggest that lutein-mediated AP-1 suppression and anti-inflammatory activity are the result of its strong antioxidative and p38/JNK inhibitory activities. These findings can be applied for the preparation of anti-inflammatory and cosmetic remedies for inflammatory diseases of the skin.

Indexed as

AnimalsAnti-Inflammatory AgentsCell LineCyclooxygenase 2HumansInterferon-gammaInterleukin-6KeratinocytesLuteinMacrophagesMatrix Metalloproteinase 9MiceReverse Transcriptase Polymerase Chain ReactionSkinTranscription Factor AP-1Tumor Necrosis Factor-alphaAnti-Inflammatory AgentsCyclooxygenase 2Interferon-gammaInterleukin-6LuteinMatrix Metalloproteinase 9Transcription Factor AP-1Tumor Necrosis Factor-alpha

Identifiers

PMID23533312
PMCPMC3606807
OpenAlexW2050107072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.